ial survival for the entire series was 65%. Cumulative incidence of postoperative strokes was higher in patients with bilateral internal CS than in patients with unilateral internal CS (p<0.07) and in patients with neurologic symptoms than asymptomatic patients. At 12 years, actuarial freedom from all cardiac related events, postoperative stroke, and symptomatic PVD were 49%, 82%, and 76% respectively. After successful revascularization these patients should be carefully followed for recurrent and progressive vascular lesions.
(Chest 1994; 106:1349-57) 15 In this series, we have studied the factors influencing the short-and the long-term prognosis in these subsets of patients.
METHODS
Between January 1980 and December 1991, 175 (3%) patients who underwent myocardial revascularization also had a significant internal carotid stenosis (luminar stenosis >80%). These patients underwent carotid endarterectomy for the dominant lesion followed by myocardial revascularization on cardiopulmonary bypass under the same anesthetic. Of Figure 1 and Tables 1 and 2 patients with no neurologic symptoms or sequelae, but later a dipyridamole thallium scan was primarily used before coronary angiography. All patients undergoing CABG with neurologic symptoms, carotid bruit, and patients older than 65 years in the study underwent carotid Doppler study. All patients included in this series had coronary angiography and four-vessel cerebral arteriogram performed at or during this same hospital admission. In the patients needing IMA grafting, extracranial cervical vessels were studied preoperatively by angiography. Fifty-five patients had significant symptomatic PVD. Of these, 18 patients underwent urgent, 29 underwent elective, and 6 patients underwent reoperation for the recurrent PVD. All peripheral vascular procedures were performed as staged procedures after combined CAE and CABG. Patients with the recurrent or progressive vascular disease (CAD, internal carotid, or PVD) were reinvestigated by noninvasive (thallium scan, Doppler duplex scan), or invasive (angiography) methods and were reoperated on if indicated. Follow-up was complete in all patients by June 1993. Patients were followed up for a total period of 9,392.6 months (792.7 years), the mean follow-up was 54.9 months (4.5 years), and minimum follow-up was 18 months. Six patients with incomplete follow-up and 29 more patients with less than 18 months' follow-up have not been included in this series. This period is desirable to assess full benefit from CAE. These patients had no neurologic deficits or MI following combined CAE and myocardial revascularization.
Statistical Analysis:
Values are mean + SEM. Paired data were compared using Student's t test. Predictors of postoperative events were analyzed by univariate analysis using x2 test. Factors with p value less than 0.1 were entered for stepwise multiple regression analysis. The following factors were entered as predictors of 
RESULTS

Postoperative Survival
Thirty-day and hospital mortality was 3.42% (6/ 175 Table 4 ). The latter two were also identified as significant predictors of late mortality on stepwise multivariate analysis; COPD had a marginally significant effect (p<0.077), and reoperations, in fact, improved patient survival (Table 5 ). (Fig 4) . At following surgery was 14.2% (n=25; 95% CI: 0.6 to 5.8%/yr). Although our symptomatic patients had a higher incidence of neurologic complications (Table  6 ), no independent predictor of major stroke was identified after CAE on the stepwise multivariate ( Table 7 ). The incidence of major stroke in the first postoperative month was higher in patient with bilateral disease than in patients with unilateral disease (5.7% vs 1.4%: NS). In patients with bilateral carotid disease, freedom from major postoperative stroke at 12 years was 73% when bilateral CAE was required (bilateral disease 285%) as compared with 88% when only unilateral CAE was required (con- tralateral stenosis <85%) (p<0.07) (Fig 7) . Fourteen in the latter subset of patients underwent prophylactic CAE for the progression of their contralateral disease at a mean interval of 4.0 ± 0.6 years after the initial CAE, which reduced the incidence of major stroke for these patients (Fig 8) . reported in the recent literature.6,9,11,13,14
Disease Pattern
Patients included in this series obviously had advanced atherosclerosis. These patients are well known to have a higher incidence of left-main coronary disease (10 to 37%), unstable angina (34 to 57%), triple-vessel CAD (40 to 80%), impaired LV function (9 to 26%), CHF (7 to 10%), and a previous episode of MI (57 to 63%).7,9-11,14,22,23 Our patients had a higher incidence of triple-vessel CAD (90%) and bilateral carotid vessel disease (60%) than has been reported earlier (34.5 to 50%).11,14 Our patients with bilateral carotid disease had a male preponderance (76%), and 38% of these patients also had coexistent PVD. Bilateral Carotid Stenosis Presence of bilateral CS, whether symptomatic or not, increases the risk of neurologic complications.14'36-39 In patients with bilateral critical stenosis (-85%) and more so in patients with unilateral occlusion, the incidence of perioperative stroke has ranged between 15.6 and 20%.11 143-39 It has been suggested that most severe stenosis or the symptomatic side should be chosen first.'4 Bilateral CAE synchronous with CABG should be considered if both cerebral hemispheres are considered to be at risk.9"4 We have found cerebral angiography most useful in such cases. Bilateral carotid endarterectomy is generally not favored because of an element of risk due to intimal flap formation, postoperative occlusion, and minor airway or swallowing problems.21 It is possible to maintain adequate cerebral perfusion during cardiopulmonary bypass,40'41 but it is not advantageous to perform CAE during bypass.23 '42 Perioperative Mortality and Morbidity As reported earlier,11"14 early mortality of our patients undergoing combined CAE and CABG was marginally higher than our patients undergoing CABG along during the same period (3.4% vs 2.4%: NS). In this series, early deaths were the result of MI occurring in patients with unstable angina and the result of preoperative stroke occurring in patients with bilateral carotid disease. Unlike previous reports, 11, 14, 18, 43 left-main CAD and presence of LVEF >-30% had no significant effect on the perioperative mortality of our patients.
As reported earlier,11"14 more late deaths occurred because of ischemic heart disease than strokes.14 In this series, other predictors of late mortality were COPD and PVD. All our patients with PVD also had triple-vessel CAD and 70% of them also had bilateral CS. This subset of our patients with multifocal atherosclerosis had least favorable long-term survival. As expected," long-term survival of our patients with bilateral carotid disease was less favorable than our patients with unilateral disease.
In this series, fatal MI occurred in 2.2% patients after combined CAE and CABG, which is within the range (0 to 5%) described earlier.6'9"1"13 Postoperative mortality and morbidity due to MI is generally lower after combined CAE and CABG than after staged intervention.25 In this series, incidence of perioperative stroke was four times higher in patients with bilateral carotid disease as compared with those who had unilateral carotid disease. In our patients with bilateral CS, an overall incidence of stroke was higher when lesions were critical on both sides than in patients who had unilateral critical stenosis. The latter underwent contralateral CAE when the lesion progressed. An elective contralateral CAE in this subset in patients has been shown to reduce the incidence of neurologic complications.31'43 As expected,"1"14 our patients with a history of neurologic symptoms had a higher incidence of late strokes than our asymptomatic patients. Our study clearly shows that CAE reduces the incidence of neeurologic deficits. In this series, recurrent CS after CAE developed in 7.4% as compared with 9 to 24% reported by others for a comparable study period. 43 Atherosclerosis is a progressive and multifocal disease. These patients should be carefully evaluated for recurrent symptoms, progression, and development of newer lesions and they should be treated accordingly. In our experience, combined CAE and CABG is the safest in technique, even in the presence of left-main CAD, recent MI, unstable angina, patients with poor LV function (LVEF, 30%), in those who required IMA as conduit, and in reoperation for recurrent CAD. Most recent reports14'44 now favor combined over staged intervention. Most of our patients with coexistent PVD underwent peripheral vascular reconstruction as staged procedures. Synchronous approach is possible when symptoms dictate.15 Angioplasty was preferred for more proximal and less severe lesions and peripheral vascular reconstruction was preferred for more distal lesions. As expected, limb salvage rate was better for proximal disease than for distal disease.
